UG Healthcare Corporation Limited (SGX:8K7)

UG Healthcare Corporation Balance Sheet

Financials in millions SGD. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	27.41	23.29	28	61.75	100.22
Cash & Short-Term Investments	27.41	23.29	28	61.75	100.22
Cash Growth	17.69%	-16.81%	-54.66%	-38.39%	46.43%
Accounts Receivable	48.6	33.82	29.95	24.51	31.18
Other Receivables	2.07	11.82	11.53	14.43	16.67
Receivables	50.67	45.65	41.48	38.93	47.85
Inventory	58.89	64.43	61.31	54.54	61.83
Prepaid Expenses	-	4.81	5.8	4.71	3.39
Other Current Assets	0.13	0.03	0.01	-	-
Total Current Assets	137.09	138.21	136.6	159.93	213.29
Property, Plant & Equipment	64.65	61.65	57.55	59.79	66.09
Long-Term Investments	11.42	10.88	10.96	7.06	6.44
Goodwill	18.42	18.42	18.42	-	-
Other Intangible Assets	4.08	4.63	4.73	0.62	0.48
Long-Term Deferred Tax Assets	4.8	2.6	3.12	2.6	1.75
Other Long-Term Assets	0.07	0.09	-	-	-
Total Assets	240.52	236.48	231.37	230	288.04

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	25.43	18.27	13.84	8.72	13.03
Accrued Expenses	-	4.78	2.82	2.5	6.18
Short-Term Debt	-	21.34	12.85	13.01	2.29
Current Portion of Long-Term Debt	20.67	2.92	5.05	3.13	3.89
Current Portion of Leases	0.9	0.4	0.51	0.58	0.8
Current Income Taxes Payable	1.61	0.14	0.43	1.66	5.57
Other Current Liabilities	0.09	3.35	2.63	3.18	5.4
Total Current Liabilities	48.7	51.2	38.13	32.78	37.16
Long-Term Debt	18.57	22.5	24.93	13.81	10.27
Long-Term Leases	0.38	0.2	0.37	0.6	0.72
Long-Term Deferred Tax Liabilities	3.11	2.25	2.34	1.62	4.82
Total Liabilities	70.75	76.15	65.77	48.81	52.98

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	59.65	59.65	59.65	59.65	59.65
Retained Earnings	174.79	172.69	176.79	180.75	205.47
Comprehensive Income & Other	-62.69	-69.59	-68.73	-59.56	-36.23
Total Common Equity	171.76	162.75	167.71	180.84	228.9
Minority Interest	-1.99	-2.42	-2.11	0.35	6.16
Shareholders' Equity	169.77	160.33	165.6	181.19	235.06
Total Liabilities & Equity	240.52	236.48	231.37	230	288.04

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	40.52	47.36	43.72	31.13	17.98
Net Cash (Debt)	-13.11	-24.07	-15.72	30.62	82.24
Net Cash Growth	-	-	-	-62.77%	59.07%
Net Cash Per Share	-0.02	-0.04	-0.03	0.05	0.13
Filing Date Shares Outstanding	623.83	623.83	623.83	623.83	623.83
Total Common Shares Outstanding	623.83	623.83	623.83	623.83	623.83
Working Capital	88.39	87.01	98.47	127.16	176.14
Book Value Per Share	0.28	0.26	0.27	0.29	0.37
Tangible Book Value	149.27	139.71	144.56	180.23	228.42
Tangible Book Value Per Share	0.24	0.22	0.23	0.29	0.37
Land	-	4.9	4.4	4.48	4.78
Buildings	-	14.33	11.13	11.84	11.77
Machinery	-	41.81	38.8	38.71	42.72
Construction In Progress	-	24.87	23.44	22.29	23.7

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 13, 2026

Data Sources Report a data error